2622 Results

People

  1. Reuter
    Reuter
  2. Fong
    Fong
  3. Motzer
    Motzer
  4. Brennan
    Brennan
  5. Akin
    Akin
  6. Eastham
    Eastham
  7. Fine
    Fine
  8. Rusch
    Rusch
  9. Abrey
    Abrey
  10. Gonen
    Gonen

Groups

  1. Department of Medicine (744)
  2. Surgery (660)
  3. Sloan Kettering Institute Faculty (490)
  4. GSK Faculty (474)
  5. Solid Tumor Oncology Division (435)
  6. Survivorship Research (381)
  7. Department of Pathology and Laboratory Medicine (272)
  8. Molecular Pharmacology and Chemistry Program Faculty (271)
  9. Population Sciences Research Program (269)
  10. Radiology, Department of (237)
  1. "2007"
Formats
  1. Journal Article (1654)
  2. Meeting Abstract (774)
  3. Book Section (162)
  4. Conference Paper (22)
  5. Book Whole (10)
Groups
  1. Department of Medicine (744)
  2. Surgery (660)
  3. Sloan Kettering Institute Faculty (490)
  4. GSK Faculty (474)
  5. Solid Tumor Oncology Division (435)
  6. Survivorship Research (381)

More Groups

People
  1. Peter Scardino (58)
  2. Victor Reuter (53)
  3. Yuman Fong (50)
  4. Oguz Akin (48)
  5. Robert Motzer (48)
  6. Murray Brennan (46)

More People

Years
  1. 2007 (2622)
Publications
  1. Journal of Clinical Oncology (228)
  2. Blood (75)
  3. Annals of Surgical Oncology (71)
  4. International Journal of Radiation Oncology, Biology, Physics (61)
  5. Modern Pathology (56)
  6. Laboratory Investigation (53)

More Publications

Publishers
  1. Elsevier Inc. (279)
  2. American Society of Clinical Oncology (229)
  3. Springer (187)
  4. Nature Publishing Group (152)
  5. American Association for Cancer Research (131)
  6. Elsevier Science, Inc. (126)

More Publishers

Results (2622)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Circulating tumor cells in patients with castration-resistant metastatic prostate cancer
    Meeting Abstract

    Danila, D. C.; Leversha, M. A.; Gonzalez-Espinoza, R.; Anand, A.; Gu, B.; Gignac, G. A.; Larson, S.; Heller, G.; Fleisher, M.; Scher, H. I.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Efficacy of neo-adjuvant gemcitabine plus cisplatin (GC) in muscle-invasive urothelial cancer (UC)
    Meeting Abstract

    Dash, A.; Pettus, J. A. 4th; Bochner, B. H.; Dalbagni, G.; Donat, S. M.; Herr, H. W.; Bajorin, D. F.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Agonist anti-GITR antibody induces CD8 T cell-mediated tumor rejection
    Meeting Abstract

    Cohen, A. D.; Diab, A.; Perales, M. A.; Duan, F.; Jenq, R.; Rizzuto, G.; Hirschorn-Cymmerman, D.; Merghoub, T.; Wolchok, J. D.; Houghton, A. N.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Pharmacokinetics (PK) of split-dose flavopiridol (F) administered with CPT-11 (CPT) and cisplatin (Cis)
    Meeting Abstract

    Carvajal, R. D.; Tse, A.; Wu, N.; Gonen, M.; Lefkowitz, R.; Dials, H.; Barbi, A.; Mui, J.; Schwartz, G. K.; Shah, M.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Improved overall survival for patients with advanced ovarian, tubal, and primary peritoneal carcinoma as a result of a change in surgical approach: A follow-up study
    Meeting Abstract

    Chi, D. S.; Eisenhauer, E. L.; Sonoda, Y.; Abu-Rustum, N. R.; Gemignani, M. L.; Levine, D. A.; Hensley, M. L.; Sabbatini, P.; Brown, C. L.; Barakat, R. R.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • The effect of corticorelin acetate on peritumoral brain edema: An interim report of an open-label study as part of a phase III program
    Meeting Abstract

    Carr, L.; Mechtler, L.; Recht, L.; Hormigo, A.; Paleologos, N.; Alksne, J. F.; Arenson, E.; Raizer, J.; Shulman, M. G.; for the CAPBrainEdema [Corticorelin Acetate Peritumoral Brain Edema] Study Group
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • XELOX compared to FOLFOX4: Survival and response results from XELOX-1/ NO16966, a randomized phase III trial of first-line treatment for patients with metastatic colorectal cancer (MCRC)
    Meeting Abstract

    Cassidy, J.; Clarke, S.; Diaz-Rubio, E.; Scheithauer, W.; Figer, A.; Wong, R.; Koski, S.; Lichinitser, M.; Yang, T.; Saltz, L.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Quality of life (QOL) predicts for progression-free survival (PFS) in patients with metastatic renal cell carcinoma (mRCC) treated with sunitinib compared to interferon-alpha (IFN-α)
    Meeting Abstract

    Cella, D.; Li, J. Z.; Cappelleri, J. C.; Bushmakin, A.; Charbonneau, C.; Kim, S. T.; Chen, I.; Michaelson, M. D.; Motzer, R. J.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • STEAP1: A potential marker of metastatic disease for Ewing family tumors
    Meeting Abstract

    Cheung, I. Y.; Feng, Y.; Danis, K.; Shukla, N.; Meyers, P.; Ladanyi, M.; Cheung, N.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Extracellular cleaved HER2 (p95) confers partial resistance to trastuzumab but not HSP90 inhibitors in models of HER2 amplified breast cancer
    Meeting Abstract

    Chandarlapaty, S.; Scaltriti, M.; Baselga, J.; Ye, Q.; Solit, D.; Norton, L.; Rosen, N.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save